GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.

Revenue
+7.19%
EPS
+40.6%
Free cash flow
+64.2%
Total debt
−1.90%

Quarter to September 2026, against a year earlier

82.39 1.36 −1.62%
Market cap
$37.9B
P/E
17.3×
Fwd P/E
15.5×
Dividend yield
0.18%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

17.99 17.03 14.68 13.74
P/S ratio
1.81 1.55 1.36 1.37
P/FCF ratio
24.85 21.37 18.36 15.64
P/Operating CF
35.62 111.92 172.60 32.58
P/B ratio
3.60 3.04 2.64 2.54
EV/Sales
2.16 1.99 1.81 1.77
EV/EBITDA
13.34 12.86 11.50 10.91
EV/FCF
29.61 27.47 24.33 20.27
Current Ratio
1.37 1.22 1.26 1.30
Net Debt/EBITDA
7.34 13.87 10.49 9.04
Debt/Equity
1.12 1.08 1.05 1.00
Earnings Yield
5.56% 5.87% 6.81% 7.28%
Free Cash Flow Yield
4.02% 4.68% 5.45% 6.39%
Free Cash Flow per Share
2.01 0.25 0.15 1.75
Book value per Share
22.79 23.42 24.26 25.73
Free Cash Flow
916.00 112.00 68.00 793.00
EV/EBIT
16.13 15.75 14.05 13.26
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026